← Back to Search

Androgen

Testosterone nasal spray for Anxiety

N/A
Waitlist Available
Led By Robert A Josephs, Phd
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Male, 18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions

Summary

The proposed study will test the effects of a fast-acting testosterone nasal spray on the fear reactions of young men to two distinct anxiety challenges (social and nonsocial) using a double-blind randomized experimental design.

Eligible Conditions
  • Anxiety

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Magnitude of behavioral approach

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Testosterone nasal sprayExperimental Treatment1 Intervention
Subjects will inhale approximately 40ml aqueous, testosterone-containing solution via intranasal route
Group II: Placebo nasal sprayPlacebo Group1 Intervention
Subjects will inhale approximately 40ml aqueous solution via intranasal route
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Testosterone propionate
FDA approved

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
374 Previous Clinical Trials
86,079 Total Patients Enrolled
11 Trials studying Anxiety
1,585 Patients Enrolled for Anxiety
Robert A Josephs, PhdPrincipal InvestigatorUniversity of Texas at Austin
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top